High altitude reduces infection rate of COVID-19 but not case-fatality rate

José Segovia Juarez, Jesús Martin Castagnetto Mizuaray, Gustavo F. Gonzales

Producción científica: Contribución a una revistaArtículo (Contribución a Revista)revisión exhaustiva

61 Citas (Scopus)


Coronavirus disease 19 (COVID-19) is a pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). It is suggested that life at high altitude may reduce COVID infections and case-fatality rates (cases/deaths). We study data from Peru COVID-19 pandemics, which first case was recorded on March 6th, 2020. By June 13, 2020 there were 6498 deaths, and 224,132 SARS-CoV-2 positives. Using data from 185 capitals of provinces with altitudes ranging from 3 to 4342¿m, we confirm previous reports that infection with COVID-19 at high altitude is reduced. However, case-fatality rate is not dependent of altitude. We have also presented first evidence that female protection towards death by COVID-19 is reduced as altitude of residence increases.
Idioma originalInglés estadounidense
PublicaciónRespiratory Physiology & Neurobiology
EstadoPublicada - 1 ene. 2020
Publicado de forma externa


  • Artículo

Categoría OCDE

  • Políticas de salud, Servicios de salud

Categorías Repositorio Ulima

  • Ciencias / Medicina y Salud

Temas Repositorio Ulima

  • Altitudes
  • Anoxemia
  • COVID-19
  • Mortalidad
  • Mortality
  • Perú


Profundice en los temas de investigación de 'High altitude reduces infection rate of COVID-19 but not case-fatality rate'. En conjunto forman una huella única.

Citar esto